Delivery Order SPE2DB20D3303-SPE2DB25FA3DN
Award Date 9/2/25
Potential Completion Date 9/3/25
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $14,317.78 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Teriparatide 560mcg/2.24ml pen injections. This is a firm fixed-price, non-set-aside contract with a completion date of July 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Teriparatide is a recombinant human parathyroid hormone used primarily in the treatment of osteoporosis and bone-related conditions. This...
- The Defense Logistics Agency awarded a $3,468.94 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Teriparatide 560mcg/2.24ml pen injections, with a completion date of July 30, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $19,119.61 delivery order to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24ml pens on August 15, 2025, with completion scheduled for August 18, 2025. This firm fixed price contract was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Teriparatide is a synthetic parathyroid hormone medication primarily used to treat osteoporosis in patients at...
- The Defense Logistics Agency awarded a delivery order valued at $5,915.41 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24ml pen injections. This is a firm fixed price, competitively awarded contract with a completion date of August 20, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract contains no set-aside designation, reflecting open competition among qualified vendors....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Teriparatide 560mcg/2.24ml pen injections with a ceiling value of $5,443.66. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion on August 12, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order operates as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for teriparatide 560 mcg/2.24 mL pen injections, valued at $5,592.67 with a firm fixed price structure. The award, issued on August 22, 2025, with completion targeted for August 25, 2025, represents a non-set-aside competitive award for pharmaceutical supply fulfillment. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed...
- The Defense Logistics Agency awarded a $6,226.08 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Teriparatide 560mcg/2.24ml pen injectors. The contract represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 11, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC)...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $2,591.28. The order is for 4,565,250,079 units of teriparatide 600 mcg/2.4 ml pen with a 2.4 ml capacity. The order has a firm fixed price and a completion date of July 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Teriparatide 560 MCG/2.24 ML pen injections, valued at $13,783.94. This non-set-aside, competitively awarded delivery order carries a firm fixed price and is scheduled for completion by August 20, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company serves as a major...
- The Defense Logistics Agency awarded a delivery order valued at $4,894.36 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560 mcg/2.24 mL pen injections. The contract, which was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a firm fixed-price delivery order under a competitive, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...